000169981 001__ 169981
000169981 005__ 20240229133702.0
000169981 0247_ $$2doi$$a10.3390/cancers13143439
000169981 0247_ $$2pmid$$apmid:34298654
000169981 0247_ $$2altmetric$$aaltmetric:110342848
000169981 037__ $$aDKFZ-2021-01681
000169981 041__ $$aEnglish
000169981 082__ $$a610
000169981 1001_ $$aKlein, Eva-Maria$$b0
000169981 245__ $$aAntibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.
000169981 260__ $$aBasel$$bMDPI$$c2021
000169981 3367_ $$2DRIVER$$aarticle
000169981 3367_ $$2DataCite$$aOutput Types/Journal article
000169981 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1627383825_7922
000169981 3367_ $$2BibTeX$$aARTICLE
000169981 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000169981 3367_ $$00$$2EndNote$$aJournal Article
000169981 520__ $$aWe compare, in this manuscript, antibiotic prophylaxis versus granulocyte-colony stimulating factor (G-CSF) support as anti-infective strategies, in patients with multiple myeloma (MM), undergoing high-dose therapy followed by autologous stem cell transplantation (HDT/ASCT). At our institution, antibiotic prophylaxis after HDT/ASCT in MM was stopped in January 2017 and replaced by G-CSF support in March 2017. Consecutive MM patients who received HDT/ASCT between March 2016 and July 2018 were included in this single-center retrospective analysis. In total, 298 patients and 353 individual cases of HDT/ASCT were evaluated. In multivariate analyses, G-CSF support was associated with a significantly shortened duration of severe leukopenia < 1/nL (p < 0.001, hazard ratio (HR) = 16.22), and hospitalization (estimate = -0.19, p < 0.001) compared to antibiotic prophylaxis. Rates of febrile neutropenia, need of antimicrobial therapy, transfer to intensive care unit, and death, were similar between the two groups. Furthermore, antibiotic prophylaxis was associated with a significantly increased risk for the development of multidrug resistant bacteria especially vancomycin-resistant Enterococcus faecium compared to G-CSF support (odds ratio (OR) = 17.38, p = 0.01). Stop of antibiotic prophylaxis as an anti-infective strategy was associated with a reduction in overall resistance rates of bacterial isolates. These results indicate that G-CSF support should be the preferred option in MM patients undergoing HDT/ASCT.
000169981 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000169981 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000169981 650_7 $$2Other$$aanti-infective strategies
000169981 650_7 $$2Other$$aantibiotic prophylaxis
000169981 650_7 $$2Other$$aautologous stem cell transplantation
000169981 650_7 $$2Other$$agranulocyte-colony stimulating factor
000169981 650_7 $$2Other$$ainfectious complications
000169981 650_7 $$2Other$$amultidrug resistant bacteria
000169981 650_7 $$2Other$$amultiple myeloma
000169981 7001_ $$aSauer, Sandra$$b1
000169981 7001_ $$aKlein, Sabrina$$b2
000169981 7001_ $$0P:(DE-He78)2ef631585610340ff425c9c31fcabd03$$aTichy, Diana$$b3$$udkfz
000169981 7001_ $$0P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aBenner, Axel$$b4$$udkfz
000169981 7001_ $$aBertsch, Uta$$b5
000169981 7001_ $$aBrandt, Juliane$$b6
000169981 7001_ $$aKimmich, Christoph$$b7
000169981 7001_ $$aGoldschmidt, Hartmut$$b8
000169981 7001_ $$aMüller-Tidow, Carsten$$b9
000169981 7001_ $$aJordan, Karin$$b10
000169981 7001_ $$aGiesen, Nicola$$b11
000169981 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers13143439$$gVol. 13, no. 14, p. 3439 -$$n14$$p3439$$tCancers$$v13$$x2072-6694$$y2021
000169981 909CO $$ooai:inrepo02.dkfz.de:169981$$pVDB
000169981 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2ef631585610340ff425c9c31fcabd03$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000169981 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000169981 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000169981 9141_ $$y2021
000169981 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2019$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-05-04
000169981 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2019$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000169981 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000169981 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000169981 980__ $$ajournal
000169981 980__ $$aVDB
000169981 980__ $$aI:(DE-He78)C060-20160331
000169981 980__ $$aUNRESTRICTED